A study by Abancens et al. provided confirmatory evidence for the suppressor effect of GPER, demonstrating its inhibitory effect on the JUN oncogene and the Wnt/β-catenin pathway, which is overactive in CRC [147]. The gene discussed is GPER1; the disease is colorectal carcinoma.